Katarina H.
- Country
- Slovakia
- Department
- Kardiologicka ambulancia
Research Overview
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation
- Evaluation of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation
Data & Insights
Has run more than one trial at 71 of 518 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in managing cardioembolic events and atrial fibrillation, with particular expertise in preventive cardiology and anticoagulation therapy.
- Stroke Prevention
- Cardioembolic Risk Management
- Atrial Fibrillation Treatment
Primary focus includes evaluation of novel therapeutic approaches for preventing systemic embolism in cardiac patients.
Thrombosis Research
Concentrated on investigating anticoagulation strategies and embolic event prevention in patients with cardiac arrhythmias.
- Novel Anticoagulants
- Systemic Embolism Prevention
- Comparative Treatment Efficacy
Expertise extends to evaluating therapeutic alternatives in anticoagulation medicine.
Clinical Cardiology
Focuses on the management of cardiac rhythm disorders and their complications, with emphasis on preventive interventions.
- Cardiac Arrhythmia Management
- Cardiovascular Risk Assessment
- Prevention Strategies
Active in developing comprehensive treatment approaches for cardiac patients requiring anticoagulation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.